Over $6,000 Raised For Breast Cancer Foundation NZ At Pink Ribbon Breakfast
The event was co-hosted by Tmaki MP Brooke van Velden and Epsom MP David Seymour with proceeds supporting research, education, and patient care across New Zealand.
More than 100 people gathered this morning to support breast cancer awareness at a Pink Ribbon Breakfast at Ōrākei Bay this morning, raising over $6,000 for Breast Cancer Foundation NZ.
The event was co-hosted by Tāmaki MP Brooke van Velden and Epsom MP David Seymour with proceeds supporting research, education, and patient care across New Zealand.
'This is a cause that touches thousands of Kiwi families every year,' said van Velden.
'It's great to see so many people from our community come together to support such an important cause.'
'Every dollar raised helps fund better outcomes for people facing breast cancer. We're grateful to everyone who came along and contributed,' said Seymour.
'A huge thank you to our guest speaker Jude Dobson, Breast Cancer Foundation NZ ambassador, for joining us and sharing her perspective. We're also incredibly grateful to the Foundation's experts who gave up their time to answer questions and engage with attendees. Their presence made the event truly meaningful.'
The breakfast was made possible thanks to the generosity of local businesses. Collective Hospitality provided the stunning Ōrākei Bay venue free of charge, ensuring that all proceeds could go directly to the Breast Cancer Foundation. Function Staff, Insphire, and The Revelry also generously donated their services.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
NZ Herald
21 hours ago
- NZ Herald
Kiwi radio host Mel Homer shares chemotherapy update amid cancer battle
Listening to articles is free for open-access content—explore other articles or learn more about text-to-speech. Kiwi radio host and television personality Mel Homer says she's still getting used to her altered appearance after finishing her first round of chemotherapy. The Breeze host was recently diagnosed with acute myeloid leukaemia – a type of cancer that affects the blood and bone marrow – which was discovered during routine blood tests in early July. Homer started a course of aggressive chemotherapy soon after. Now, more than one month in, Homer shared an update about how her treatment is progressing, noting her long locks have disappeared for the time being. 'I'm still getting used to jumping out of the shower and glancing in the mirror to see this,' Homer wrote on Facebook.
Scoop
4 days ago
- Scoop
Faster Access To Neurosurgery For South Islanders
Minister of Health Fewer South Island patients are waiting for life-changing neurosurgery, with more people getting the specialist treatment they need faster, Health Minister Simeon Brown says. 'Neurosurgery is vital for treating serious brain and spinal conditions that can dramatically affect lives if left too long,' Mr Brown says. 'Putting patients first means making sure every Kiwi can access timely, quality healthcare when they need it, and that is exactly what our focus is on for the South Island.' Between November 2023 and March 2025, the number of people waiting for neurosurgery in the South Island has fallen by 22 per cent, from 98 to 76. The number waiting longer than four months for surgery has dropped by 45 per cent, from 31 to 17. 'This is great progress, and it is making a real difference to people's lives. 'Whether it is a parent needing urgent brain surgery to be there for their children, or a worker recovering from spinal treatment and returning to their community, this is about delivering for patients.' This improvement follows a difficult period when the neurosurgery waitlist in the South Island rose by 92 per cent between 2020 and 2023, putting extra pressure on patients and health services. 'These results show our focus on reducing waitlists is delivering. We are investing in surgical teams, boosting capacity, and working closely with hospitals to ensure more New Zealanders get the specialist care they need sooner. 'This progress also reflects the hard work and dedication of our frontline health professionals, whose commitment to patient care is critical to achieving these results. 'We're also focused on ensuring that the longest waiting patients get the care they need. That's why it's encouraging to see not only the total waitlist coming down, but the number of people waiting more than four months reducing at a faster rate of 45 per cent. 'This is all part of our plan to provide timely, quality healthcare for every New Zealander. If you need specialist treatment like neurosurgery, you should be able to get it when you need it.' Reducing wait times for elective procedures is a key priority for this Government. Our health target is clear – by 2030, 95 per cent of patients will be treated within four months. 'Patients are still waiting too long, and there is still more work to do, but this latest data shows we are heading in the right direction,' Mr Brown says.
RNZ News
5 days ago
- RNZ News
Advertising unapproved medicines not legal, despite government claim
In a statement, Minister for Regulation David Seymour said the restriction on advertising new medicines at medical conferences "is being removed". Photo: RNZ / Mark Papalii Despite a government announcement suggesting it has lifted the ban on advertising unapproved medicines, it remains a criminal offence, warn legal experts. In a joint media release with Health Minister Simeon Brown, Minister for Regulation David Seymour welcomed "confirmation" of two major medical conferences in New Zealand next year, following the rule change to allow advertising of unapproved medicines at trade shows. The Ministry for Regulation had found the "overly cautious approach" was out of step with other recognised jurisdictions, and the government "acted fast to fix it", Seymour said. However, leading intellectual property lawyer Paul Johns - head of litigation for Pearce IP - cautioned the law had not yet changed. "If I were the organiser of these conferences and had seen those media releases, I would be making sure that my sponsors were aware that in fact the law has not changed and any medicines they want to advertise ought to be approved, because the consequences are criminal - there are fines and even imprisonment. "I don't think you would get that far, but they're there." Parliament was currently considering some amendments to the Medicines Act (to enable faster approval of drugs and widen powers for nurse prescribers) but there was nothing to do with advertising, he said. "It's still possible that the government could submit an amendment paper and put this advertising thing in there as well, but they haven't. So they appear to have a policy but they've done nothing about it in terms of legislation." The "great irony" was that under the Therapeutic Products Act - which was repealed by the current administration - the government could have simply introduced new regulations allowing such advertising, Johns noted. "But now they need to amend the Medicines Act." Others have pointed out that medical conferences were planned years in advance, so the new policy could not have been the deciding factor for next year's bookings. In a written response to RNZ's questions, Minister Seymour said the restriction on advertising new medicines at medical conferences "is being removed". "Ending New Zealand's prohibition on advertising medicines at medical conferences and trade shows has sent a message that New Zealand is open for business. That's exactly what medical conference organisers needed to hear, with two already confirmed for 2026." Medicines New Zealand chief executive Dr Graeme Jarvis said New Zealand had been missing out on conferences worth up to $90 million a year because it was impossible to run trade shows alongside them. "So you're actually losing out on not only the income you would get from running the conference and trade show here, but also the tourism spend as well." Clinicians had also been missing out. "Doctors here aren't getting exposed to all of the latest and greatest in terms of conferences, scientific exchange, the information and updates on all sorts of things." However, Auckland University associate professor of psychological medicine David Menkes said it was "misleading" to suggest doctors did not already have access to the latest information about new treatments. "But usually that information comes not from a company rep, it will come from an expert who's presenting as a colleague, rather than as an exhibitor or a sponsor of a conference." The academic psychiatrist said doctors liked to "believe they can't be swayed by corporate largesse" - but studies showed they were not immune. "That's why academic journals require peer review and disclosure of interests." Menkes is a long-time critic of New Zealand's permissive marketing regime : it is the only OECD country - apart from the United States - to allow direct-to-consumer advertising of medicines. Further loosening of the rules could compound the risk of over-prescribing, he said. "You don't want to be held up by red tape and bureaucracy, right? But you also want to have checks and balances in place. "I'm afraid this new policy doesn't have adequate checks and balances against overt promotional behaviour by vested interests." Seymour's office was unable to say when the government was planning to turn the policy into something Parliament could consider.
